Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1987 3
1989 2
1990 3
1991 6
1992 6
1993 2
1995 3
1997 2
1998 10
1999 19
2000 20
2001 8
2002 13
2003 16
2004 12
2005 14
2006 13
2007 16
2008 10
2009 10
2010 16
2011 12
2012 10
2013 10
2014 8
2015 17
2016 12
2017 7
2018 6
2019 14
2020 15
2021 7
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

316 results

Results by year

Filters applied: . Clear all
Page 1
The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells.
Hu Z, Artibani M, Alsaadi A, Wietek N, Morotti M, Shi T, Zhong Z, Santana Gonzalez L, El-Sahhar S, Carrami EM, Mallett G, Feng Y, Masuda K, Zheng Y, Chong K, Damato S, Dhar S, Campo L, Garruto Campanile R, Soleymani Majd H, Rai V, Maldonado-Perez D, Jones S, Cerundolo V, Sauka-Spengler T, Yau C, Ahmed AA. Hu Z, et al. Among authors: cerundolo v. Cancer Cell. 2020 Feb 10;37(2):226-242.e7. doi: 10.1016/j.ccell.2020.01.003. Cancer Cell. 2020. PMID: 32049047 Free article.
TAP deficiency syndrome.
Gadola SD, Moins-Teisserenc HT, Trowsdale J, Gross WL, Cerundolo V. Gadola SD, et al. Among authors: cerundolo v. Clin Exp Immunol. 2000 Aug;121(2):173-8. doi: 10.1046/j.1365-2249.2000.01264.x. Clin Exp Immunol. 2000. PMID: 10931128 Free PMC article. Review. No abstract available.
Capturing the antigen landscape: HLA-E, CD1 and MR1.
Ogg G, Cerundolo V, McMichael AJ. Ogg G, et al. Among authors: cerundolo v. Curr Opin Immunol. 2019 Aug;59:121-129. doi: 10.1016/j.coi.2019.07.006. Epub 2019 Aug 21. Curr Opin Immunol. 2019. PMID: 31445404 Review.
Classification of current anticancer immunotherapies.
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G. Galluzzi L, et al. Among authors: cerundolo v. Oncotarget. 2014 Dec 30;5(24):12472-508. doi: 10.18632/oncotarget.2998. Oncotarget. 2014. PMID: 25537519 Free PMC article. Review.
Biology of CD1- and MR1-restricted T cells.
Salio M, Silk JD, Jones EY, Cerundolo V. Salio M, et al. Among authors: cerundolo v. Annu Rev Immunol. 2014;32:323-66. doi: 10.1146/annurev-immunol-032713-120243. Epub 2014 Jan 31. Annu Rev Immunol. 2014. PMID: 24499274 Review.
Immunotherapy of melanoma.
Smith C, Cerundolo V. Smith C, et al. Among authors: cerundolo v. Immunology. 2001 Sep;104(1):1-7. doi: 10.1046/j.1365-2567.2001.01297.x. Immunology. 2001. PMID: 11576213 Free PMC article. Review. No abstract available.
Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell-mediated toxicity against glioblastoma.
Ma R, Rei M, Woodhouse I, Ferris K, Kirschner S, Chandran A, Gileadi U, Chen JL, Pereira Pinho M, Ariosa-Morejon Y, Kriaucionis S, Ternette N, Koohy H, Ansorge O, Ogg G, Plaha P, Cerundolo V. Ma R, et al. Among authors: cerundolo v. Neuro Oncol. 2022 Dec 1;24(12):2093-2106. doi: 10.1093/neuonc/noac107. Neuro Oncol. 2022. PMID: 35468205 Free PMC article.
316 results